March 2025
Agramunt, S. and Lenton, S. (2025). Expanded access to intranasal naloxone among police officers in Western Australia: A pilot evaluation study. Drug and Alcohol Review. DOI: https://doi.org/10.1111/dar.14032
Aung, P., Hellard, M., Dietze, P., Petrovic, B., Higgs, P. and Stoove, M.A. (2024). Practical solutions to resolve social barriers to hepatitis C treatment initiation among people who inject drugs: a qualitative study. Harm Reduction Journal, 21, (1). DOI: https://doi.org/10.1186/s12954-024-01136-1
Bade R, Nadarajan D, Hall W, Brown JA, Schumann J. Early identification of the use of potent benzylbenzimidazoles (nitazenes) through wastewater analysis: two years of data from 22 countries. Addiction 2025; March 18. https://doi.org/10.1111/add.70027.
Bartram A, Mittinty M, Ahad M.A, Bogomolova S, Dono J, Brownbill A, Harrison N, Garcia J, Glavinic I, May M, Bowden J. (2025). Alcohol advertising in disguise: Exposure to zero-alcohol products prompts adolescents to think of alcohol – reaction time experimental study. International Journal of Drug Policy. https://doi.org/10.1016/j.drugpo.2025.104753
Beck A.K., Larance B., Manning V., Deane F.P., Baker A.L., Hides L., Shakeshaft A., Argent A., Kelly P.J. (2025). Exploring the potential of Self-Management and Recovery Training (SMART Recovery) mutual-help groups for supporting people who use methamphetamine: A qualitative study examining participant experience of initiation and engagement. Journal of Substance Use and Addiction Treatment, 169, 209570. doi.org/10.1016/j.josat.2024.209570
Bharat C., Hopkins R.E., Chambers M., Degenhardt L., Peacock A., Farrell M., Yuen W.S., Man N., Gisev N. (2025). Age, period, and cohort trends of substance poisoning, alcohol-related disease, and suicide deaths in Australia, 1980–2019. Social Psychiatry and Psychiatric Epidemiology, 60(3), 693-703. doi.org/10.1007/s00127-024-02749-4
Bowden J, Bartram A, Harrison N.J, Norris C.A, Kim S, Pettigrew S, Olver I, Jenkinson R, Bowshall M, Miller C & Room R. Australian parents’ attitudes, perceptions and supply of alcohol to adolescents: a national cross-sectional survey. Health Promotion International, Volume 39, Issue 6, December 2024, daae173, https://doi.org/10.1093/heapro/daae173
Brett J., Cesta C.E., Gillies M.B., Bateman B.T., Chan A.Y.L., Cheng M.C.Y., Cho Y., Choi E.Y., Cohen J.M., Donald S., Furu K., Gissler M., Gomes T., Havard A., Hernandez-Diaz S., Hsieh M.H.C., Huybrechts K.F., Karlsson P., Kelty E., Lai E.C.C., Ledlie S., Wang T., Leinonen M.K., Parkin L., Reutfors J., Shin J.Y., Su C.T.T., Varney B., Wong I.C.K., Man K.K.C., Zoega H. (2025). Global trends in analgesic opioid use in pregnancy: A retrospective cohort study. Anesthesiology. doi.org/10.1097/ALN.0000000000005418
Bruno C., Cesta C.E., Hjellvik V., Ulrichsen S.P., Bjørk M.-H., Esen B.Ö., Gillies M.B., Gissler M., Havard A., Karlstad Ø., Leinonen M.K., Nørgaard M., Pearson S.-A., Reutfors J., Furu K., Cohen J.M., Zoega H. (2025). Corrigendum to Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study. eClinicalMedicine, 81, 103139. doi.org/10.1016/j.eclinm.2025.103139
Butt, J.C., Wilkes, E.T., Jones, J., Ripley, E. and Stearne, A. (2024). Harmful alcohol and other drug use and its implications for suicide risk and prevention for First Nations people: a companion paper. catalogue number IMH 027. AIHW, Australian Government. ISBN: 978-1-923272-51-4 DOI: https://doi.org/10.25816/030a-gk32
Butt, J.C., Wilkes, E.T., Ripley, E., Jones, J. and Stearne, A. (2024). Harmful use of alcohol and other drugs and its relationship with the mental health and wellbeing of First Nations people: a review of the key issues, policy and practice approaches. catalogue number IMH 26. AIHW, Australian Government. ISBN: 978-1-923272-45-3 DOI: https://doi.org/10.25816/21e6-0749
Caluzzi, G., Kepa, K., Torney, A., Livingston, M., Mojica-Perez, Y., Taylor, N., Callinan, S. and Pennay, A. (2025). Local environments, accessibility and affordability: A qualitative analysis of alcohol purchasing across different socio-economic areas in Victoria, Australia. Drug and Alcohol Review. DOI: https://doi.org/10.1111/dar.14018
Campbell G., Settumba S., Hopkins R., Nielsen S., Larance B., Bruno R., Cohen M., Degenhardt L., Shanahan M. (2025). A discrete choice experiment: Understanding patient preferences for managing chronic non-cancer pain. European Journal of Pain, 29(3), e4760. doi.org/10.1002/ejp.4760
Chan, J., Cook, J., Curtis, M., Dunlop, A., Morrison, E., Nielsen, S., Winter, R. and Naren, T. (2025). National Consensus Statement on opioid agonist treatment in custodial settings. Medical Journal of Australia. DOI: https://doi.org/10.5694/mja2.52603
Chatterton ML, Perez JK, Lee YY, Le LK-D, Birrell L, Slade T, Mewton L, Hides L, McBride N, Allsop S, Furneaux-Bate A, Bryant Z, Ellem R, Baker MJ, Quinn C, Chapman C, Newton NC, Teesson M, Mihalopoulos C. Cost-utility analysis of a school-based universal program for the prevention of anxiety, depression, and substance use: the Climate Schools Combined Trial. International Journal of Mental Health and Addiction 2024; December 5. https://doi.org/10.1007/s11469-024-01423-9.
Chatterton, M.L., Perez, J.K., Lee, Y., Le, L.K., Birrell, L., Slade, T., Mewton, L., Hides, L., McBride, N., Allsop, S., Furneaux-Bate, A., Bryant, Z., Ellem, R., Baker, M., Quinn, C., Chapman, C., Newton, N.C., Teesson, M. and Mihalopoulos, C. (2024). Cost-Utility Analysis of a School-Based Universal Program for the Prevention of Anxiety, Depression, and Substance Use: The Climate Schools Combined Trial. International Journal of Mental Health and Addiction. DOI: https://doi.org/10.1007/s11469-024-01423-9
Chidwick K., Bharat C., Gisev N., Havard A., Camacho X., Pearson S.-A., Degenhardt L. (2025). Trends in prescription opioid analgesic use in Australia from 2015 to 2022. International Journal of Drug Policy, 135, 104666. doi.org/10.1016/j.drugpo.2024.104666
Chung JYC, Lim CCW, Connor JP, Hall W, Stjepanović D, Chan GCK. Examining the relationship of cannabis use patterns, mental health, and sociodemographic factors: a focus on cannabis vaping, smoking and dual-use. Addictive Behaviors 2025; 163. https://doi.org/10.1016/j.addbeh.2025.108263.
Clifford B., Peacock A., Siefried K.J., Gobeil J., Smith J.L., Ezard N. (2025). Responding to reports of nitazene toxicity in Australia. Medical Journal of Australia. doi.org/10.5694/mja2.52605
Coney L., Peacock A., van der Gouwe D., Smit-Rigter L., Hutten N., Ventura M., Quesada A., Barratt M.J. (2025). Comparison of strength and adulteration between illicit drugs obtained from cryptomarkets versus off-line. Addiction, 120(1), 128-137. doi.org/10.1111/add.16665
Connor JP, Scott JG, Hall WD, Thai PK. Addressing the undertreatment of mood disorders in Australian youth. Australian and New Zealand Journal of Psychiatry 2025; 59. https://doi.org/10.1177/00048674241312795.
Conroy D, Bartram A. Wide-Ranging Responses to Temporary Abstinence Challenges Among UK-Based Heavier Drinkers: A Three-Wave Longitudinal Interpretative Phenomenological Analysis. Qualitative Health Research. 2025;0(0). doi:10.1177/10497323251320913
Darke S, Farrell M, Hall W, Lappin J. 'Deaths of despair': a term that needs to be retired. Addiction 2025; February 25. https://doi.org/10.1111/add.70030.
Darke S., Duflou J., Chrzanowska A., Farrell M., Lappin J., Peacock A. (2025). Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023. Drug and Alcohol Review, 44(1), 366-375. doi.org/10.1111/dar.13940
Darke S., Farrell M., Hall W., Lappin J. (2025). ‘Deaths of despair’: A term that needs to be retired. Addiction. doi.org/10.1111/add.70030
Darke S., Farrell M., Lappin J. (2025). Rare but relevant series. Addiction, 120(2), 197. doi.org/10.1111/add.16697
Darke S., Peacock A., Duflou J.A., Farrell M., Lappin J. (2025). Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000–24: analysis of NCIS data. Medical Journal of Australia. doi.org/10.5694/mja2.52604
Davies E.L., Perman-Howe P., Seddon J., Piatkowski T., Puljevic C., Barratt M.J., Winstock A.R., Ferris J.A. (2025). Barriers to the use of no and low alcohol products in high-risk drinkers. Drug and Alcohol Review. doi.org/10.1111/dar.14006
Davies, T., O'Brien, P., Bowden, J., Strauli, B., Yusoff, A., Jongenelis, M., Jones, A., Brownbill, A., Chikritzhs, T.N., Stafford, J. and Pettigrew, S. (2025). Suboptimal uptake and placement of a mandatory alcohol pregnancy warning label in Australia. International Journal of Drug Policy, 135. DOI: https://doi.org/10.1016/j.drugpo.2024.104661
Dietze, P., Colledge-Frisby, S., Gerra, G., Poznyak, V., Campello, G., Kashino, W., Dzhonbekov, D., Kiriazova, T., Nikitin, D., Terlikbayeva, A., Horsburgh, K., Busse, A. and Krupchanka, D. (2025). Impact of UNODC/WHO S-O-S (stop-overdose-safely) training on opioid overdose knowledge and attitudes among people at high or low risk of opioid overdose in Kazakhstan, Kyrgyzstan, Tajikistan and Ukraine. Harm Reduction Journal, 22, (1).
Djordjevic, F., Stewart, A., Vella-Horne, D., Gleeson, Z., Pavlyshyn, D., Gill, M., Petrovic, R., Scott, N., Higgs, P., Roth, A., Cocchiaro, B., Dietze, P. and O'Keefe, D. (2024). Feasibility and acceptability of multiple methods of recording injecting drug use episode data among people who inject drugs in Melbourne, Australia: A pilot evaluation study protocol. BMJ Open, 14, (12). DOI: https://doi.org/10.1136/bmjopen-2024-091613
Duflou J. (2025). Rare but relevant: The injection of tablet preparations and pulmonary hypertension. Addiction. doi.org/10.1111/add.70012
El-Hayek, C., Nguyen, T., Hellard, M., Curtis, M., Sacks-Davis, R., Aung, H.L., Asselin, J., Boyle, D., Wilkinson, A., Polkinghorne, V., Hocking, J.S. and Dunn, A. (2024). Phenotyping people with a history of injecting drug use within electronic medical records using an interactive machine learning approach. Digital Medicine, 7, (346). DOI: https://doi.org/10.1038/s41746-024-01318-y
Farrugia, A.C., Pienaar, K. and Dennis, F. (2025). Narcofeminist affects: Gender, harm and fun in young women and gender diverse people's experiences of alcohol and other drug consumption. Sociological Review. DOI: https://doi.org/10.1177/00380261251317318
Fletcher K., Ezard N., Siefried K.J., MacDonald H., Acheson L., Bedi G., Guerin A., Knock E., Millard M., May R., Brett J., Doumany J., Morgan C., Clifford B. (2025). Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychotherapy for methamphetamine use disorder (the KAPPA trial). BMJ Open, 15(2), e092504. doi.org/10.1136/bmjopen-2024-092504
Freestone J., Xiao B.J., Siefried K.J., Bourne A., Ezard N., Maher L., Stirling R., Degenhardt L., Varma R., Prestage G., Hammoud M. (2025). Exploring experiences of talk therapies among gay and bisexual men seeking to reduce or abstain from using crystal methamphetamine in the context of chemsex. Drug and Alcohol Review. doi.org/10.1111/dar.13999
Freestone J., Xiao B.J., Siefried K.J., Bourne A., Ezard N., Maher L., Stirling R., Degenhardt L., Varma R., Prestage G., Hammoud M. (2025). Exploring experiences of talk therapies among gay and bisexual men seeking to reduce or abstain from using crystal methamphetamine in the context of chemsex. Drug and Alcohol Review, 44(3), 711-722. doi.org/10.1111/dar.13999
Grigg, J. and Lenton, S. (2024). Western Australian Drug Trends 2024: Key Findings from the Ecstasy and Related Drugs Reporting System (EDRS) Interviews. National Drug and Alcohol Research Centre, UNSW, Sydney, NSW. DOI: https://doi.org/10.26190/unsworks/30686
Gupta R, Goel S, Bostic C, et al. Tobacco-free generation: reflecting on progress globally and its potential feasibility in India. Tobacco Control. Published Online First: 07 January 2025. https://doi.org/10.1136/tc-2024-059064
Harrison N.J, Dodd R.H, Sharman A.R, Marshall H.M, Stone E, Rhee J.J, Yap M.L, McCullough S, Paul C, Bowden J.A, Bonevski B & Rankin N.M. (2025). “Because that is the right thing to do”: A focus group study of Australian expert perspectives on offering smoking cessation support in lung cancer screening. Nicotine and Tobacco Research, 27(3), 387-397. https://doi.org/10.1093/ntr/ntae215
Harrod M.E., Sunjic S., Pepolim L., Aylmer R., Skelley N., Lintzeris N. (2025). Evaluation of an online postal take-home naloxone service. Drug and Alcohol Review. doi.org/10.1111/dar.14017
Harrod M.E., Sunjic S., Pepolim L., Aylmer R., Skelley N., Lintzeris N. (2025). Evaluation of an online postal take-home naloxone service. Drug and Alcohol Review. doi.org/10.1111/dar.14017
Hatton E.L., Kelly P.J., Bruno R., Neale J., Larance B. (2025). Measuring recovery among people who have completed residential rehabilitation: Factor structure and scoring of the substance use recovery evaluator. Drug and Alcohol Review. doi.org/10.1111/dar.14004
Haywood, S. and Lenton, S. (2024). Western Australian Drug Trends 2024: Key Findings from the Illicit Drug Reporting System (IDRS) Interviews. National Drug and Alcohol Research Centre, UNSW, Sydney, NSW. DOI: https://doi.org/10.26190/unsworks/30681
Hefler M. Centering equity and justice in tobacco control Tobacco Control 2024;33:e141-e142
Hefler M. The ‘tobacco endgame’ in an age of disinformation: rising to the challenge Tobacco Control 2025;34:1-2. https://doi.org/10.1136/tc-2024-059257
Henderson A., Shakeshaft A., Allan J., Wallace R., Barker D., Farnbach S. (2025). A pilot study examining the impact of a pragmatic process for improving the cultural responsiveness of non-Aboriginal alcohol and other drug treatment services using routinely collected data in Australia. Journal of Health Services Research and Policy, 30(1), 4-11. doi.org/10.1177/13558196241261800
Hoch E, Hall W, Feingold D. Editorial: Cannabis use in Europe. European Archives of Psychiatry and Clinical Neuroscience 2025; 275: 277-9. https://doi.org/10.1007/s00406-025-01972-7.
Howard B.C., Donnelly S., McRobbie H., Barker D., Petrie D., Stockings E., Brown J., Naughton F., Whittaker R., Shakeshaft A., Patel K., Anderson J., Thomas D., West R., Courtney R.J. (2025). Tailored text-messaging versus standard Quitline telephone counselling for smoking cessation among people who smoke from a low-socio-economic status background in Australia: A study protocol for a non-inferiority randomized controlled trial (The Quit By Phone Study). Addiction, 120(1), 174-183. doi.org/10.1111/add.16662
Johnson B, Sun T, Wu L, Seal S, Stjepanovic D, Chan G, Leung J. Content analysis of the portrayal of prescription stimulants on TikTok. Journal of Attention Disorders 2025; February 18. https://doi.org/10.1177/10870547251318834.
Karlsson A, Peacock A, Sutherland R. Drug-related encounters which did not result in arrest, among two national samples of people who regularly use drugs in Australia, 2023-2024. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2025. doi.org/10.26190/unsworks/30787
Ke, T., Livingston, M., Zhang, Y., Pavlyshyn, D., Altermatt, A., Thomas, A.J., Nguyen, T., Walker, S., Hill, S., Coelho, A., Pedrana, A., Stoove, M.A., Hellard, M., Gibney, K.B. and Wilkinson, A. (2024). A longitudinal study of alcohol consumption among adults in Victoria, Australia during the COVID-19 pandemic. PLOS One, 19, (12). DOI: https://doi.org/10.1371/journal.pone.0313599
Kypri K, Austin E, Jackson M, Wright K, Shui A, Li A, Sathasivam V, Bonevski B, & Dunlop A. J. (2025). Vaping to quit smoking: Qualitative study of people receiving opioid agonist treatment. Drug and Alcohol Review, 44(1), 254-266. https://doi.org/10.1111/dar.13953
Lenton, S., Potter, G.R., Fortin, D., Granville, A., Grigg, J., Sevigny, E.L., Wilkins, C., Decorte, T. and Barratt, M.J. (2024). Growing practices and the use of potentially harmful chemical additives from a web survey of mainly small-scale cannabis growers in 18 countries. International Journal of Drug Policy. DOI: https://doi.org/10.1016/j.drugpo.2024.104662
Li W., Paul C.L., Baker A.L., Byaruhanga J., Dizon J., Chiu S., Tzelepis F. (2025). Quit attempts, use of smoking cessation treatments and quitting intention among treatment seekers in rural areas. Journal of Substance Use and Addiction Treatment, 169, 209603. doi.org/10.1016/j.josat.2024.209603
Lim CCW, Lawrie E, Wilson H, Hall W, Dawson D, Yimer TM. Research Letter: Unveiling the boundaries: analysing advertising breaches in the promotion of medicinal cannabis in Australia. Australian and New Zealand Journal of Psychiatry 2025; 59: 183-6. https://doi.org/10.1177/00048674241307158.
Lindson N., Butler A.R., McRobbie H., Bullen C., Hajek P., Wu A.D., Begh R., Theodoulou A., Notley C., Rigotti N.A., Turner T., Livingstone-Banks J., Morris T., Hartmann-Boyce J. (2025). Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews, 2025(1), CD010216. doi.org/10.1002/14651858.CD010216.pub9
Lovell T., Mitchell M., Powell M., Strube P., Tonge A., O'Neill K., Dunstan E., Bonnin-Trickett A., Miller E., Suliman A., Ownsworth T., Ranse K. (2025). An interprofessional multicomponent intervention to improve end-of-life care in intensive care: A before-and-after study. Australian Critical Care, 38(3), 101147. doi.org/10.1016/j.aucc.2024.101147
McCarthy SDS, Gaudreault A, Xiao J, Fischer B, Hall W, Lee K, Kang R, Aslanyan G, Sood MM, Myran DT. Evaluating the association between cannabis decriminalization and legalization and cannabis arrests and related disparities: a systematic review. International Journal of Drug Policy 2025; 137. https://doi.org/10.1016/j.drugpo.2025.104705.
Mendelsohn CP, Beaglehole R, Borland R, Hall W, Wodak A, Youdan B, Chan GCK. Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies? Addiction 2025; February 9. https://doi.org/10.1111/add.70006.
Miller, P.G., Taylor, N., Egerton-Warburton, D., Baker, T.R., Kloot, K., Shepherd, J. and Akhlaghi, H. (2025). Using emergency department data to reduce late-night alcohol-related presentations in an Australian central business district. Injury Prevention. DOI: https://doi.org/10.1136/ip-2024-045362
Nip J, Stanley J, Zhang J, Waa A, Ball J, Tautolo E-S, Johnson E, Agar T, Quah ACK, Fong GT, Edwards R. Support for and likely impacts of endgame measures in the Smokefree Aotearoa Action Plan: Finding from the 2020-2021 International Tobacco Control New Zealand (EASE) Surveys. NZMJ 2025; 138 (1608 ): 40-83. https://doi.org/10.26635/6965.6526
Nuske J, Nuske L, Hides L, King DL. Evaluating the effect of detached mindfulness techniques on gaming-related urges and intentions to play. Addictive Behaviors 2024; December 16. https://doi.org/10.1016/j.addbeh.2025.108258.
O'Donnell, R., Martin, J.G., Taylor, N., Mitchell, G., Henriques-Cadby, I., Cook, M., Laslett, A.L. and Morojele, N.K. (2024). Alcohol guidelines, post-incarceration social network dynamics, alcohol’s harms to others, drinking and cannabis use in private schools. International Journal of Alcohol and Drug Research, 12, (2), pp. 42-44. DOI: https://doi.org/10.7895/ijadr.571
Pellatt, R., Painter, D.R., Young, J.T., Kõlves, K., Keijzers, G., Kinner, S.A., Heffernan, E. and Crilly, J. (2025). The risk of repeated self-harm and suicide after emergency department presentation with self-harm in mental health presenters: a retrospective cohort study with data linkage in Queensland, Australia. The Lancet Regional Health - Western Pacific, 54. DOI: https://doi.org/10.1016/j.lanwpc.2024.101263
Pettigrew S, Yusoff A, Sträuli B, Booth L, O’Brien P, Bowden J, Brownbill A, Stafford J, Jongenelis M.I, Davies T, Chikritzhs T, Stockwell T, Taylor F & Jones A. The prevalence of mandated and voluntary health information on alcohol products in Australia. Australian and New Zealand Journal of Public Health, 2025. ISSN 1326-0200. 4 Feb 2025. https://doi.org/10.1016/j.anzjph.2024.100215
Pettigrew, S., Sträuli, B., Yusoff, A., O'Brien, P., Bowden, J., Jongenelis, M., Brownbill, A., Chikritzhs, T.N., Petticrew, M., Matheson, A., Taylor, F. and Jones, A. (2025). “There's just a lot of numbers and I just want to have a drink”: The challenge of communicating the energy content of alcohol products. Appetite, 205. DOI: https://doi.org/10.1016/j.appet.2024.107700
Pettigrew, S., Yusoff, A., Strauli, B., Booth, L., O'Brien, P., Bowden, J., Brownbill, A., Stafford, J., Jongenelis, M., Davies, T., Chikritzhs, T.N. and Stockwell, T.R. (2025). The prevalence of mandated and voluntary health information on alcohol products in Australia. Australian and New Zealand Journal of Public Health, 49, (1). DOI: https://doi.org/10.1016/j.anzjph.2024.100215
Piatkowski T., Coomber R., Francis C., Kill E., Davey G., Cresswell S., White A., Harding M., Blakey K., Reeve S., Walters B., Puljevic C., Ferris J., Barratt M. (2025). The world's first anabolic-androgenic steroid testing trial: A two-phase pilot combining chemical analysis, results dissemination and community feedback. Addiction. doi.org/10.1111/add.70009
Piatkowski T., Volpe I., Brien R., Coomber R., Barratt M., Kill E., Davey G., Francis C., Cresswell S., White A., Harding M., Blakey K., Reeve S., Walters B., Ferris J., Puljević C. (2025). Development, dissemination and community response towards the first community notice regarding misrepresented illicit anabolic-androgenic steroids in circulation in Australia. Drug and Alcohol Review. doi.org/10.1111/dar.14015
Pocuca N, Campbell G, Barnett A, Beck AK, Ellem R, Quinn CA, Kelly PJ, Larance B, Baker AL, Connor JP, Marsden J, Chan GCK, Connelly L, Lenzen S, Farrell M, Stirling R, Hudson S, Hides L. A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatment. Drug and Alcohol Review 2025; 44: 759-71. https://doi.org/10.1111/dar.14007.
Pocuca N, Campbell G, Ellem R, Newland G, Walter Z, Dignan J, Stokes H, Hides L. Three-month polysubstance use patterns among people enrolled in outpatient treatment for methamphetamine use. Substance Use & Misuse 2025; 60: 775-85. https://doi.org/10.1080/10826084.2024.2447437.
Pocuca N., Campbell G., Barnett A., Beck A.K., Ellem R., Quinn C.A., Kelly P.J., Larance B., Baker A.L., Connor J.P., Marsden J., Chan G.C.K., Connelly L., Lenzen S., Farrell M., Stirling R., Hudson S., Hides L. (2025). A mixed-methods study of staff perspectives on the barriers and facilitators to the implementation of patient-reported routine outcome measures and feedback in alcohol and other drug treatment. Drug and Alcohol Review. doi.org/10.1111/dar.14007
Pocuca N., Tisdale C., Campbell G., Beck A.K., Ellem R., Quinn C.A., Kelly P.J., Larance B., Baker A.L., Connor J.P., Marsden J., Chan G.C.K., Connelly L., Lenzen S., Farrell M., Hides L. (2025). Routine outcome monitoring and feedback in alcohol and other drug treatment: A qualitative study of client perspectives on implementation. Drug and Alcohol Review, 44(1), 226-238. doi.org/10.1111/dar.13962
Reilly R., McKetin R., Barzi F., Degan T., Ezard N., Conigrave K., Butt J., Roe Y., Wand H., Quinn B., Longbottom W., Treloar C., Dunlop A., Ward J. (2025). Web-Based Application for Reducing Methamphetamine Use Among Aboriginal and Torres Strait Islander People: Randomized Waitlist Controlled Trial. Journal of Medical Internet Research, 27, e58341. doi.org/10.2196/58341
Ritter A., Bell J., Strang J., Ezard N., Rodgers C., Belackova V., Jauncey M., Siefried K.J., Roberts D.M., van den Brink W., Lintzeris N., Dunlop A., Oviedo-Joekes E., Treloar C. (2025). Bridging the evidence and the politics: Implementation trial of supervised injectable opioid treatment (SIOT) in Australia. International Journal of Drug Policy, 138, 104749. doi.org/10.1016/j.drugpo.2025.104749
Roberts E., Copeland C., Darke S., Farrell M. (2025). Characteristics of drug-related deaths where individuals are found submerged in a bath or hot tub in the United Kingdom, 1997–2023. Drug and Alcohol Review, 44(1), 347-354. doi.org/10.1111/dar.13950
Roxburgh A., Van Buskirk J., Roberts D.M., Stoove M., Raubenheimer J., Dietze P., Reid S., Haber P.S., Day C.A. (2025). Treatment completion among Australians attending publicly-funded specialist alcohol and other drug treatment services. Journal of Substance Use and Addiction Treatment, 169, 209588. doi.org/10.1016/j.josat.2024.209588
Roxburgh, A., Van Buskirk, J., Roberts, D., Stoove, M.A., Raubenheimer, J.E., Dietze, P., Reid, S., Haber, P. and Day, C.A. (2024). Treatment completion among Australians attending publicly-funded specialist alcohol and other drug treatment services. Journal of Substance Use and Addiction Treatment, 169. DOI: https://doi.org/10.1016/j.josat.2024.209588
Saad C, Cheng B, Takamizawa R, Thakur A, Lee C-W, Leung L, Veerman JL, Aminde LN. Effectiveness of tobacco advertising, promotion and sponsorship bans on smoking prevalence, initiation and cessation: a systematic review and meta-analysis. Tobacco Control 2025. https://doi.org/10.1136/tc-2024-058903.
Santo T.J., Jr., Chaillon A., Martin N., Hickman M., Jones N., Farrell M., Bharat C., Degenhardt L., Borquez A. (2025). Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study. Addiction. doi.org/10.1111/add.70018
Saunders J.B., Rumpf H.-J., Carragher N., Poznyak V. (2025). The Development of and Rationale for Gaming Disorder in ICD-11 and a Review of Available Assessment Tools. Current Addiction Reports, 12(1), 18. doi.org/10.1007/s40429-025-00631-0
Settumba S., Shahbazi J., Byrne M., Degenhardt L., Grebely J., Larance B., Nielsen S., Lintzeris N., Ali R., Rodgers C., Blazey A., Weiss R., Dunlop A., McDonough M., Cook J., Farrell M. (2025). Provider costs of treating opioid dependence with extended-release buprenorphine in Australia. Drug and Alcohol Review, 44(1), 179-194. doi.org/10.1111/dar.13956
Siefried K.J., Acheson L., Clifford B., Moller C., Brett J., Christmass M., Dunlop A.J., Haber P.S., Jutras-Aswad D., Lintzeris N., Morley K., Shoptaw S., Trivedi M.H., Ezard N. (2025). Trial protocol of an open-label pilot study of oral naltrexone-bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial). BMJ Open, 15(2), e092032. doi.org/10.1136/bmjopen-2024-092032
Simpson, P., Guthrie, J., Jones, J., Haire, B. and Butler, T. (2025). Ethical issues in conducting health research with people in prison: Results of a deliberative research project conducted with people in Australian prisons. Social Science and Medicine, 367. DOI: https://doi.org/10.1016/j.socscimed.2025.117751
Smit, K., Rintala, J., Riordan, B.C., Lee, K.S. and Laslett, A.L. (2025). Parental alcohol use and the level of child protection response in Australia (2012-21). Addiction, 120, (2), pp. 347-357. DOI: https://doi.org/10.1111/add.16677
Stewart A.C., Hickman M., Agius P.A., Scott N., Stone J., Roxburgh A., O'Keefe D., Higgs P., Kerr T., Stoové M.A., Thompson A., Crawford S., Norman J., Vella-Horne D., Lloyd Z., Clark N., Maher L., Dietze P. (2025). Supervised Injecting Room Cohort Study (SIRX): study protocol. BMJ Open, 15(2), e091337. doi.org/10.1136/bmjopen-2024-091337
Stewart, A., Hickman, M., Agius, P., Scott, N., Stone, J., Roxburgh, A., O'Keefe, D., Higgs, P., Kerr, T., Stoove, M.A., Thompson, A. and Crawford, S. (2025). Supervised Injecting Room Cohort Study (SIRX): study protocol. BMJ Open, 15, (2), pp. e091337.
Stewart, A., Hickman, M., Agius, P., Scott, N., Stone, J., Roxburgh, A., O'Keefe, D., Higgs, P., Kerr, T., Stoove, M.A., Thompson, A. and Crawford, S. (2025). Supervised Injecting Room Cohort Study (SIRX): study protocol. BMJ Open, 15, (2), pp. e091337. DOI: https://doi.org/10.1136/bmjopen-2024-091337
Stewart, A., Hickman, M., Agius, P., Scott, N., Stone, J., Roxburgh, A., O'Keefe, D., Higgs, P., Kerr, T., Stoove, M.A., Thompson, A. and Crawford, S. (2025). Supervised Injecting Room Cohort Study (SIRX): study protocol. BMJ Open, 15, (2), pp. e091337. DOI: https://doi.org/10.1136/bmjopen-2024-091337
Stewart, A., Hickman, M., Agius, P., Scott, N., Stone, J., Roxburgh, A., O'Keefe, D., Higgs, P., Kerr, T., Stoove, M.A., Thompson, A., Crawford, S., Norman, J.S., Vella-Horne, D., Lloyd, Z., Clark, N., Maher, L. and Dietze, P. (2025). Supervised Injecting Room Cohort Study (SIRX): study protocol. BMJ Open, 15, (2), pp. e091337. DOI: https://doi.org/10.1136/bmjopen-2024-091337
Tayeb H, Peacock A, Sutherland R. The use of nicotine pouches among people in Australia who regularly consume illicit substances, 2024. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2025. doi.org/10.26190/unsworks/30858
Twyman L, Walsberger S, Baker A. L, Ahmadi S, Oldmeadow C, Weber M, Lawn S, Hefler M, Bowman J, Boss P, Ko K, Scott A, Fienberg B, Watts C, Brooks A, Ireland R & Bonevski, B. (2025). Outcomes of an organisational change program aimed at increasing smoking cessation support within Australian community managed mental health organisations: A cluster randomised controlled trial. Addiction. Advance online publication. https://doi.org/10.1111/add.16733
Uporova J, Peacock A, Sutherland R. Patterns of re-using own needles among a sample of people who regularly injects illicit drugs in Australia, 2008-2024. Drug Trends Bulletin Series. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney; 2025. doi.org/10.26190/unsworks/30857
Vieira, E., Taylor, N., Stevely, A.K., Pennay, A., Raninen, J., Holmes, J., Vashishtha, R. and Livingston, M. (2025). A systematic review of adolescent alcohol-related harm trends in high-income countries with declines in adolescent consumption. Addiction. DOI: https://doi.org/10.1111/add.70026
Waa A, Ball J, Edwards R, Hoek J. Will the Government’s new Smokefree Plan achieve Aotearoa’s smokefree goal? The Briefing, Public Health Communications Centre Aotearoa. December 17 2024. https://www.phcc.org.nz/briefing/will-governments-new-smokefree-plan-achieve-aotearoas-smokefree-goal
Walker, S., Rathnayake, K., Dietze, P., Higgs, P., Ward, B., Hellard, M., Doyle, J.S., Stoove, M.A. and Maher, L. (2025). Disproportionate, differential and targeted treatment: people who use drugs’ experiences of policing during the COVID-19 pandemic. Health & Justice, 13, (6). DOI: https://doi.org/10.1186/s40352-024-00314-4
Weatherburn D., Rahman S., Todd S., Poynton S., Black S., Merinda T., Farrell M. (2025). The impact of a voluntary alcohol and other drug diversion program on reoffending, imprisonment, and health. International Journal of Drug Policy, 138, 104747. doi.org/10.1016/j.drugpo.2025.104747
Wilson J, Langcake A, Bryant Z, Freeman TP, Leung J, Chan GCK, Englund A, Graham M, Stockings E. The safety and efficacy of cannabinoids for the treatment of mental health and substance use disorders: protocol for a systematic review and meta-analysis. Systematic Reviews 2025; 14: 23. https://doi.org/10.1186/s13643-024-02657-3.
Wolfenden, L. and Slevin, T. (2025). 2025: A year of uncertainty and opportunity for public health. Australian and New Zealand Journal of Public Health, 49, (1). DOI: https://doi.org/10.1016/j.anzjph.2025.100227
Wong G., Cheng A., Cheng K., Masoe A., D'Hary S., Montebello M.E. (2025). Exploring oral health challenges and integration strategies in opioid treatment programs: perspectives from clinicians and clients. Australian Journal of Primary Health, 31. doi.org/10.1071/PY24134
Woods A., Foley C., Conigrave K.M., Asare-Doku W., Shakeshaft A., Settumba-Stolk S., Farrell M., Doyle M. (2025). Extended-release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review. Addiction. doi.org/10.1111/add.16766
Yimer TM, Hoch E, Fischer B, Dawson D, Hall W. The adverse public health effects of non-medical cannabis legalisation in Canada and the USA. Lancet Public Health 2025; 10: e148-e59. https://doi.org/10.1016/s2468-2667(24)00299-8.
Zhou C., Lavender I., Gordon R., McCartney D., Kevin R.C., Bedoya-Pérez M.A., McGregor I.S. (2025). An analysis of the cultivation, consumption and composition of home-grown cannabis following decriminalisation in the Australian Capital Territory. Scientific Reports, 15(1), 2649. doi.org/10.1038/s41598-024-84897-w
Zolopa C., Brothers T.D., Leclerc P., Mary J.-F., Morissette C., Bruneau J., Martin N.K., Hyshka E., Larney S. (2025). Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018–2022. International Journal of Drug Policy, 137, 104711. doi.org/10.1016/j.drugpo.2025.104711